Skip to main content

Table 1 Demographic and clinical characteristics of the study population.

From: Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study

  Severe GHD (n = 38) Mild GHD (n = 16) Controls (n = 20) p-value
Age 44.9 ± 14.0 48.2 ± 10.6 45.5 ± 12.0 NS
Gender (M/F) 23/15 3/11 9/11 NS
NYHA class 1.3 ± 0.5 1.1 ± 0.1 1.2 ± 0.1 NS
Body mass index 29.7 ± 6.8 31.4 ± 4.8 28.6 ± 4.4 NS
SBP (mmHg) 134.1 ± 16.1 133.6 ± 17.6 128.1 ± 10.3 NS
DBP (mmHg) 79.5 ± 10.8 81.8 ± 9.8 78.5 ± 11.1 NS
SBP > 135 and/or DBP > 85 mmHg 11 (28.4) 6 (37.5) 5 (25%) NS
GH-peak (ng/mL) 0.97 ± 0.84 8.31 ± 3.31 NA <0.0001
IGF-1 (ng/mL) 94.3 ± 64.6 130.5 ± 65.8 NA <0.05
FT3 (mmol/L) 4.2 ± 1.2 4.9 ± 1.6 5.3 ± 0.9 NS
FT4 (mmol/L) 12.9 ± 4.0 15.5 ± 3.8 14.2 ± 2.9 NS
  1. Values are mean ± SD.
  2. Legends: DBP, Diastolic Blood Pressure; GH, Growth Hormone; IGF-1, Insulin-Like Growth Factor; NA, Not Applicable; NYHA, New York Heart Association Functional Class; SBP, Systolic Blood Pressure; FT3, Free Triiodothyronine; FT4, Free Thyroxine.